home / stock / adma / adma news

ADMA News and Press, ADMA Biologics Inc

Stock Information
Company Name: ADMA Biologics Inc
Stock Symbol: ADMA
Market: NASDAQ
Website: admabiologics.com
Menu
Get ADMA Alerts

News, Short Squeeze, Breakout and More Instantly...
ADMA - ADMA Biologics announces $125M accelerated share repurchase with JPmorgan

2026-03-02 07:46:49 ET More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript ADMA Biologics: Business Update And My Price Target ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADM...
ADMA - ADMA Biologics Announces $125 Million Accelerated Share Repurchase with JPMorgan as Part of a Planned $200 Million 2026 Total Share Repurchase Initiative

RAMSEY, N.J. and BOCA RATON, Fla., March 02, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, ...

ADMA - ADMA Biologics (ADMA) Q4 2025 Earnings Transcript

2026-02-28 00:37:29 ET Image source: The Motley Fool. Wednesday, Feb. 25, 2026 at 4:30 p.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

ADMA - ADMA forecasts $635M revenue for 2026 as ASCENIV drives margin expansion and new supply deals extend growth runway

2026-02-25 18:28:29 ET More on ADMA Biologics ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript ADMA Biologics: Business Update And My Price Target ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript ADM...
ADMA - ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call Transcript

2026-02-25 18:27:52 ET ADMA Biologics, Inc. (ADMA) Q4 2025 Earnings Call February 25, 2026 4:30 PM EST Company Participants Adam Grossman - Co-Founder, President, CEO & Director Brad Tade - CFO & Treasurer Terry Kohler ... Read the full article on...

ADMA - ADMA Biologics GAAP EPS of $0.20 beats by $0.02, revenue of $139.16M misses by $0.64M

2026-02-25 16:29:20 ET More on ADMA Biologics ADMA Biologics: Business Update And My Price Target ADMA Biologics, Inc. (ADMA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript The Play On ADMA Biologics: A Discounted Stock With Good Prospects ...

ADMA - ADMA Biologics Reports Record Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update

FY 2025 Total Revenue of $510 Million, Representing 20% Year-Over-Year Growth FY 2025 ASCENIV Revenue Grew to $363 Million, Representing 51% Year-Over-Year Growth FY 2025 Adjusted Net Income ( 1) of $161 Million, Representing 35% Year-Over-Year Growth FY 2025 Adjusted EBITDA ( 2) ...
ADMA - ADMA Biologics to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026

RAMSEY, N.J. and BOCA RATON, Fla., Feb. 18, 2026 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, t...

ADMA - Stanley Druckenmiller's Duquesne initiates position in Goldman Sachs, exits Meta in Q4

2026-02-17 16:11:18 ET More on related tickers C.PR.R: A 6.25% Preferred Stock IPO From Citigroup Bank Of America: It Doesn't Have To Be An Or/Or Story Fed proposes rules to bring mortgages back to the big banks Goldman Sachs to drop DEI criteria for its boar...

ADMA - Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth

2026-02-14 13:10:19 ET On February 13, 2026, Ranger Investment Management, L.P. disclosed a buy of 197,073 shares of Solaris Energy Infrastructure (NYSE:SEI) , an estimated $9.53 million trade based on quarterly average pricing. According to a filing with the Securities and Ex...
Next 10